Clinical Trials Browser

Interventional × Liquid Biopsy × Clear all

NCT03265496 2026-03-17

CONCORDE

Phase NA Terminated

Carcinoma, Non-Small-Cell Lung

NCT07432308 2026-03-06

Liquid biopsy

Phase NA Completed

Carcinoma, Non-Small-Cell Lung

NCT07418125 2026-02-18

GALIA

Phase NA Recruiting

Breast Neoplasms, Neoplastic Cells, Circulating

NCT06068075 2026-01-22

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

Phase NA Recruiting

Sarcoma, Ewing, Neuroectodermal Tumors, Primitive, Peripheral

NCT07358715 2026-01-22

Liquid Biopsy-Based Pre-Screening to Streamline LDCT Lung Cancer Screening in High-Risk Individuals

Phase NA Recruiting

Lung Neoplasms

NCT05708599 2026-01-21

A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer

Phase NA Active not recruiting

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT05868486 2026-01-02

Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer

Phase EARLY_PHASE1 Active not recruiting

Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT07257718 2025-12-02

FUTURE

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

NCT05384769 2025-10-07

Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer

Phase NA Recruiting

Lung Neoplasms

NCT06989814 2025-08-11

SMART

Phase NA Recruiting

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Colorectal Neoplasms

NCT05810402 2025-07-10

LILIPSY

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05283044 2025-06-25

PRISM-POrTAL

Phase NA Recruiting

10,000 enrolled

Neoplasm Metastasis

NCT06067503 2025-04-22

Biomarkers to Detect Endocrine Therapy Resistance

Phase 2 Recruiting

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Carcinoma, Lobular

NCT05298722 2025-04-02

PeRFormanCe

Phase NA Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT04474613 2025-02-05

Liquid Biopsy to Reduce Time to Treatment for Advanced Nonsquamous NSCLC Diagnosed at Outside Sites

Phase NA Terminated

Carcinoma, Non-Small-Cell Lung

NCT05255133 2025-01-06

Liquid-NET

Phase NA Completed

Neuroendocrine Tumors

NCT06268405 2024-10-01

Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast Screenings

Phase NA Recruiting

Breast Neoplasms

NCT04253106 2024-09-23

LISA-HDGC

Phase NA Completed

Gastrointestinal

Stomach Neoplasms

NCT02890849 2024-02-23

RadImm01

Phase NA Completed

NSCLC

NCT04223492 2023-12-28

LIMA

Phase NA Completed

Breast Neoplasms

NCT06090214 2023-10-19

BLADE

Phase NA Unknown

Adenocarcinoma, Neoplastic Cells, Circulating

NCT05964153 2023-08-30

Analysis of Circulating DNA in Blood Samples of Glioma-affected Patients

Phase NA Unknown

Glioma, Neoplastic Cells, Circulating

NCT05814224 2023-04-14

MAGNETIC1

Phase NA Unknown

Breast Diseases, Breast Neoplasms

NCT05245435 2023-03-20

Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer

Phase NA Withdrawn

Prostatic Neoplasms

NCT05268952 2022-03-07

A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)

Phase NA Unknown

Neuroendocrine Tumors

NCT03942380 2021-09-21

Cell-free Tumor DNA in Head and Neck Cancer Patients

Phase NA Unknown

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms

NCT04079699 2019-09-06

Predicting Prostate Cancer in Elderly Men

Phase NA Not yet recruiting

Disease, Prostatic Neoplasms